share_log
Breakings ·  Aug 12 18:31
Apogee Therapeutics: Phase 1 Apg808 Trial on Track for 4Q 2024 Interim Data Readout
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment